☰
Five Prime Therapeutics, Inc. has recently revealed the 1st pre-clinical data of the anti-CCR8 FPA157 program. The pre-clinical results were presented at the SITC (Society for Immunotherapy of Cancer)’s 35th Anniversary Annual Meeting....
Buoy Health Inc., the AI-based healthcare navigation platform, has reportedly raised USD 37.5 million in a Series C funding round led by Humana Inc. and Cigna Holding Co. The funding round also marked the presence of other companies includi....
Opear MD, a membership-based app, has reportedly announced two promotions to improve affordability and accessibility of patients to healthcare during the COVID-19 pandemic. Opear MD app provides remote digital healthcare through its on-dem....
7 Hills Pharma, a clinical stage immunotherapy company that develops drugs and treatment options for preventing cancer and infectious diseases, has reportedly announced that the initiation of Phase 1 trial of 7HP349. According to the credib....
Clinical stage biopharmaceutical major, Liminal Biosciences Inc., has reportedly announced the extension of its Ryplazim BLA (Biologics License Application) by the U.S. Food and Drug Administration for the treatment of clinical symptoms and....
NanOlogy LLC, a renowned clinical-stage oncology firm working on intratumoral therapy for solid tumors, has reportedly enrolled the very first patient for its Phase 2 clinical study of NanoPac, its intratumoral injection candidate to treat ....
Meat-Tech 3D, a leading developer of cultivated meat production technologies that uses advanced 3D bioprinting, has reportedly announced that it raised $7 million from a new investment round that was led by Tel Aviv based Psagot Provident &....
Swish Data, Northern Virginia-based trusted Service-Disabled Veteran-Owned Small Business (SDVOSB) provider of technology solutions, has reportedly partnered with Check Point Software Technologies Ltd. to help a U.S. Federal supply chain ma....
Sanofi signed a contract with Kiadis, a clinical-stage biopharmaceutical establishment developing advanced ‘off the shelf’ natural killer (NK) cell-based drugs for the treating of severe diseases. According to the deal, the form....
Imugene Ltd., a biotechnology firm that specializes in cancer immunotherapy, has recently bagged an investigational new drug (IND) approval from the US Food and Drug Administration (FDA) to commence the Phase-1 clinical study of PD1-Vaxx, o....
